The cancer treatment developer raised $52.8m, floating beneath its $14 to $16 range, as existing backer Fidelity invested $8m.

Digital diabetes treatment developer WellDoc has added Johnson & Johnson to a Samsung and Merck & Co-backed series B round now sized at $29.5m.

Rose-Hulman Institute of Technology reinvests in Nico to support its neurosurgery medical devices and its plans to commercialise more products and expand geographically.

Medical device maker OrthoFix was part of a $5.75m round that will help fund development of Bone Biologics' bone graft substitute.

Leeds University and IP Group take part in a $6.4m round for medical imaging company Quantum Imaging to support commercialisation efforts.

Strategic investor UPMC led the series B round, which also featured LabCorp and Envision Healthcare, and which Vivify first began raising in 2014.

The healthcare data software provider took its overall funding to more than $220m in a round featuring UPMC, MultiCare Health System, OSF Healthcare, Partners HealthCare, Kaiser Permanente and Indiana University Health.

UPMC and Merck have invested $35m in MedCPU as UPMC prepares to acquire a majority stake in the healthcare IT company.

2015 saw companies raising large VC rounds faster and investors existing quicker, according to Jon Norris of Silicon Valley Bank, and expect M&A to stay steady as IPO market continues to move slowly.